• The QbD Group launches its new Business & Communications division

    Monday September 18th 2023

  • SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV

    Friday September 8th 2023

  • The QbD Group acquires life sciences consultancy Azierta to reinforce its global vigilance services and expand its presence in Spain

    Tuesday September 5th 2023

  • SwiftPharma and AntoXa Corporation sign exclusive collaboration agreement to support the development and commercialization of a plant-made antibody against ricin exposure

    Friday September 1st 2023

  • SwiftPharma and ONO Exponential Farming join forces in an exclusive strategic alliance to develop a circular biomanufacturing platform based on plant molecular farming

    Wednesday August 9th 2023

  • ‘Human inks’ to 3D printing human tissues: HU3DINKS project brings together expert companies for the development of human tissue-based inks

    Monday July 24th 2023

  • Biocartis appoints George Cardoza as new CFO and Head of Service Delivery

    Tuesday July 18th 2023

  • Benoît van Den Hove steps up as new CEO of Euronext Brussels

    Tuesday July 4th 2023

  • Your news here?

  • With the platform Startup.Flanders, Flanders claims its place among international start-up ecosystems

    Friday June 16th 2023

  • Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer

    Friday June 16th 2023

  • ΛCTIV by Aphea.Bio® launched in Poland

    Monday June 12th 2023

Strategic Partners